Inside Indiana Business [1] |
Lilly Pulls Plug on Potential Diabetes Treatment [1]
Inside Indiana Business (NYSE: LLY) says it is discontinuing development of a highly-regarded potential diabetes treatment [2]. Lilly Diabetes President Enrique Conterno says, while the company was encouraged by efficacy data for basal insulin peglispro, “we know that moving … Lilly stops development of diabetes treatment [3]Reuters Lilly Abandons Diabetes Treatment [4]TelegraphTimes.com (blog) Eli Lilly Ends Development of Potential Diabetes Treatment [5]Pharmaceutical Processing all 47 news articles » [6] |
More details can be found at www.diabeteshowto.com [7]